We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Hybrigenics Presentation at the American Bio Investor Forum, October 6, 2010 in San Francisco

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Hybrigenics Presentation at the American Bio Investor Forum, October 6, 2010 in San Francisco"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:
Hybrigenics, a bio-pharmaceutical company listed on Alternext in Paris, with a focus on research and development of new cancer treatments and with a 100 per cent subsidiary dedicated to specialized services in protein interactions, will take part in the 9th Annual BIO Investor Forum organised by the Biotechnology Industry Organisation in San Francisco on October 5 and 6, 2010.

At the event, Hybrigenics’ management will present the major strategic breakthroughs achieved during the current financial year, and notably the definitive results of the Phase IIa clinical trials obtained with its flagship product, Inecalcitol, on October 6 at 8.30 am local time, i.e. 5.30 pm Paris time.

Hybrigenics’ participation in this prominent North American Forum for the biotechnology sector is in line with the Company’s commitment to strengthen its relations with its investors and to increase its visibility within the financial community.